Join Now

Category Archives: Life Sciences Industry News

PhotoPharmics Stay-At-Home Trial for People with Parkinson’s

By Denise Bell | Published July 17, 2020

This week, PhotoPharmics announced a collaboration with the Center for Health + Technology (CHeT) at the University of Rochester Medical Center to conduct an at home, telemedicine, phase 3 trial for the company’s Celeste® – a non-invasive, specialized light therapy device for Parkinson’s. The trial follows an FDA Breakthrough Device Designation for the device in […]

Also posted in BioUtah News, Federal News, Utah's Life Sciences Companies | | Leave a comment

Jim Greenwood: Thank You and Looking Forward

By admin | Published May 29, 2020

A letter from departing BIO president Jim Greenwood originally sent May 27, 2020 After more than fifteen years as President and CEO of BIO, I will pass the baton to Michelle McMurry-Heath on June 1st. It has been a fascinating period for me and for the biotechnology sector. I am proud of the unparalleled team […]

| Leave a comment

Alucent Biomedical Announces First Patient Enrolled in Phase 1 Natural Vascular Scaffolding Clinical Trial

By admin | Published May 29, 2020

Multicenter ACTIVATE I Study to Enroll up to 15 Patients in the U.S. SALT LAKE CITY – May 27, 2020 –  (Alucent Biomedical) Alucent Biomedical Inc. announced that it has enrolled the first two patients in ACTIVATE I, a Phase 1 clinical trial to evaluate the safety and efficacy of its revolutionary Natural Vascular Scaffolding […]

Also posted in BioUtah News | | Leave a comment

FDA Clears Park City-Based Transit Scientific’s XO Cross Microcatheter Platform

By admin | Published May 13, 2020

Park City, Utah USA, May 12, 2020 /PRNewswire/ — Transit Scientific announced the FDA cleared the XO Cross Microcatheter platform for guidewire support, exchange, and contrast media injection in the peripheral vasculature. Microcatheters are small 0.70-1.30mm outer diameter (OD) catheters used to provide guidewire support, facilitate guidewire exchanges, access distal anatomy, cross lesions, deliver therapeutic […]

| Leave a comment

Impactful Innovation Exchange: Calling all Solutions!

By admin | Published May 8, 2020

How can we advance the utilization of innovations in healthcare? By lending them extra visibility to key stakeholders! Join the Impactful Innovation Exchange, a free comprehensive platform that will showcase solutions from various organizations, created by Cambia Grove, with supporting organizations including BioUtah. Learn more and submit yours for FREE today: https://bit.ly/CGInnovationSubmission

Also posted in Life Sciences Events | | Leave a comment

Silver lining: opportunities can arise from the corona crisis

By Kelvyn Cullimore | Published May 7, 2020

Author: Anja Petschauer Co-authors: Anna Derschang, Melitta Gilllespie gwSaar has been a member of BioUtah and a trusted partner of the State of Utah for many years. As a German investment promotion agency, we can observe the economic trends developing in our crisis-stricken global economy first-hand. We are honored that BioUtah has asked us to provide […]

Also posted in BioUtah News | | Leave a comment

PhotoPharmics Gets FDA Breakthrough Status for Parkinson’s PhotoTherapy

By admin | Published May 1, 2020

PhotoPharmics, a pioneer in specialized phototherapy, announced on April 29, that it has received FDA Breakthrough device designation for the company’s non-invasive Specialized Phototherapy Device. “Hats off to Utah’s PhotoPharmics,” said Kelvyn Cullimore, president and CEO of BioUtah. “Earning this Breakthrough designation is a significant value driver for a privately-owned device company.” “Our device is […]

| Leave a comment

FDA Grants Breakthrough Designation for Non-Invasive Phototherapy Device in Parkinson’s Disease

By admin | Published April 30, 2020

PhotoPharmics achieves priority designation for innovative PD therapy April 29, 2020, Salt Lake City, UT— PhotoPharmics, a pioneer in specialized phototherapy, today announced that it has received FDA Breakthrough device designation for the company’s non-invasive Specialized Phototherapy Device. This prescription device is intended as an adjunct therapy for the treatment of Parkinson’s disease. It is […]

| Leave a comment

FDA Clears New Disposable Fog-Free Articulating 5mm Laparoscope

By admin | Published April 17, 2020

SALT LAKE CITY, April 14, 2020 /PRNewswire/ — Xenocor, Inc. announced the FDA cleared the new Xenocor Disposable 5mm Articulating Laparoscope for minimally invasive abdominal and thoracic surgery. The Xenoscope 5mm articulating disposable laparoscope is designed to improve image quality, reduce fog, lower hospital costs, and reduce bio-hazard risk for the patient and staff. Read the article below on […]

| Leave a comment

Romney Announces Resource to Keep Utahns Informed on Coronavirus

By admin | Published March 23, 2020

WASHINGTON—U.S. Senator Mitt Romney (R-UT) today announced the launch of a new webpage designed to keep Utahns informed during the coronavirus pandemic. The webpage, which serves as a reference guide for information from federal agencies, as well as state and local authorities, includes guidance for seniors and at-risk individuals, veterans, families and small businesses. The […]

Also posted in Federal News | | Leave a comment

Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide

By Denise Bell | Published March 20, 2020

Teva will donate 6 Million tablets through wholesalers to hospitals by March 31, and more than 10 Million within a month TEL AVIV, Israel & PARSIPPANY, N.J.–(BUSINESS WIRE)– Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the immediate donation of more than 6 million doses of hydroxychloroquine sulfate tablets through wholesalers to hospitals […]

Also posted in Utah's Life Sciences Companies | | Leave a comment

Rep. Curtis Sends Letter to Treasury Department Advocating for Small Business Relief

By admin | Published March 20, 2020

FOR IMMEDIATE RELEASE: March 20, 2020 Media Contact: Ally Riding (202) 226-7721   Washington, DC— Today, Representative John Curtis (R-UT) sent a letter to United States Department of the Treasury Secretary Steven Mnuchin asking for relief for small businesses who are obligated to make paid leave payments to employees under the newly signed Families First […]

Also posted in Federal News | | Leave a comment

A Special Thanks To Our Elite Members